US SEC Filing Intelligence

Federal Construction & Infrastructure Contracts — April 30, 2026

The single contract analyzed totals $328,507,039 in obligations, entirely civilian with 0/1 defense-related, dominated by Department of State infrastructure spending on embassy construction. Caddell Construction Co. (DE), LLC secured this full and open competition award for a new embassy compound in Praia, Cape Verde, providing a bullish signal with $80M estimated annual revenue over ~4.1 years through 2028-11-08. This represents a significant, fully obligated firm fixed price revenue stream for the Montgomery, AL-based firm in NAICS 236220 commercial building construction. Highest-conviction signal is bullish growth for Caddell in State Department projects. Key risk is high pricing risk under firm fixed price terms with $0 outlayed to date; watch outlay progress and performance through 2028.

DHS Homeland Security Contracts — April 30, 2026

DHS awarded $353,996,604 in civilian contracts (0/2 defense-related) to General Atomics Aeronautical Systems, Inc. ($272.6M) and Rapiscan Systems Inc. ($81.4M), both to U.S. Customs and Border Protection (CBP) for UAS operations/maintenance and non-intrusive inspection equipment repair. The dominant theme is CBP sustainment of border security technologies, with the highest-conviction bullish signal on Rapiscan Systems Inc./OSI Systems, Inc. ($81.4M obligation, $42.7M outlayed, up to $153M ceiling through 2027). General Atomics' larger award shows neutral stability but low outlay progress ($34.3M vs. $272.6M obligated). Key watch item: outlay acceleration on both contracts amid potential option exercises.

2 total filings

HHS & Healthcare Contracts Intelligence — April 30, 2026

HHS's BARDA awarded a single $150,780,000 cost-no-fee definitive contract to Trustees of Boston University for CARB-X Global Antibacterial Accelerator OTA R&D, comprising 100% civilian obligations with 0/1 defense-related. This 2022 award, running to May 31, 2029 (potentially 2032), has $75,505,831 outlayed and 107 subawards totaling $63,748,654, emphasizing subcontracting in NAICS 541714 biotechnology R&D. The dominant agency theme is BARDA's sustained commitment to health preparedness basic research (PSC AN41). Highest-conviction signal is low pricing risk on this full-and-open competition award to the nonprofit university. Key watch item is progress on the remaining ~$75M obligation and potential exercise of options to reach the $285,780,000 ceiling.

New Federal Contractors — April 30, 2026

These six new federal contracts total $1,188,107,721 in obligations, entirely civilian with 0/6 defense-related, highlighting sustained non-DOD spending across State, DHS, NSF, and HHS agencies. Dominant themes include embassy construction (State), border security sustainment (DHS), IT services (NSF), and health preparedness R&D/waste management (HHS), with average signal strength of 5.7/10. Highest-conviction bullish signals stem from Caddell Construction's $328.5M State embassy build and Booz Allen Hamilton's $254.5M NSF IT delivery order, both via full/open competition signaling competitive strength. Key risk is high fixed-price execution exposure on Caddell ($328.5M), Inmar RX ($100.3M), and Rapiscan ($81.4M) contracts, alongside variable outlay progress (e.g., $0 on Caddell). Watch multi-year option exercises and outlay ramps through 2027-2029 for revenue visibility.

Significant Contract Modifications ($10M+) — April 30, 2026

These six significant civilian contract modifications total $1,188,107,721 in obligations, with 0/6 defense-related awards spanning State, DHS (two), NSF, and HHS (two) agencies. Dominant themes center on long-term construction (Caddell $328.5M State embassy), IT services (Booz Allen $254.5M NSF), and sustainment services in health R&D/preparedness (HHS) and border security (DHS). Highest-conviction bullish signals emerge from Caddell Construction's fully obligated $328.5M firm-fixed-price embassy project and Booz Allen Hamilton's $254.5M IT order with $179.6M outlaid. Key risk is high pricing/execution exposure on firm-fixed-price awards like Caddell ($328.5M, $0 outlaid), Inmar RX ($100.3M), and Rapiscan ($81.4M).

Contract Deobligations Alert — April 30, 2026

This Contract Deobligations Alert synthesizes six civilian agency contracts totaling $1,188,107,721 in obligations, with 0/6 defense-related, highlighting sustained federal spending in construction, IT services, UAS maintenance, health R&D, and waste disposal despite the one-day reporting period in April 2026. Dominant themes center on Department of State infrastructure (Caddell at $328.5M), DHS support services ($354M combined for General Atomics and Rapiscan/OSI Systems), and HHS R&D/waste management ($251M for Boston University and Inmar RX). Highest-conviction bullish signals include Caddell Construction's fully obligated $328.5M embassy project and Booz Allen Hamilton's $254.5M NSF IT delivery order with $179.6M outlayed. Neutral signals dominate lower-materiality awards, but firm fixed-price execution risks on Caddell ($328.5M), Inmar RX ($100.3M), and Rapiscan ($81.4M) warrant monitoring alongside outlay progress on low-spend contracts like Caddell's $0 outlay.

Contract Option Exercises — April 30, 2026

This digest covers $1,188,107,721 in contract option exercises across 6 civilian awards (0 defense-related) from April 30, 2026 to April 30, 2026, dominated by Department of State, DHS, HHS, and NSF spending in construction, IT services, UAS maintenance, health R&D, waste disposal, and inspection equipment repair. Highest-conviction bullish signals emerge from Caddell Construction's $328.5M State embassy build and Booz Allen Hamilton's $254.5M NSF IT delivery order, both fully obligated via full and open competition with multi-year visibility to 2028 and 2025. Rapiscan's $81.4M DHS contract adds border security tailwinds for OSI Systems. Key risk: High firm-fixed-price execution risks on Caddell ($328.5M), Inmar ($100.3M), and Rapiscan ($81.4M) amid low-to-moderate outlays; watch option exercises and outlay progress across all.

Federal IT & Cybersecurity Contracts — April 30, 2026

The single contract analyzed totals $254,534,977 in obligations, entirely civilian with zero defense-related awards from the National Science Foundation (NSF). Booz Allen Hamilton Inc secured this major IT services delivery order under full and open competition, signaling strong positioning in civilian agency IT with $179.6M already outlayed and multi-year visibility through January 2025. The highest-conviction bullish signal is Booz Allen's reliable revenue stream from this NSF award, estimated at ~$46M annually. A key watch item is progress toward full $254.5M obligation and option exercises for the additional $2.45M ceiling, amid medium pricing risk.

All HHS Contracts — April 30, 2026

HHS awarded $251,069,100 in total obligations across two civilian contracts (0/2 defense-related) during April 30, 2026, focused on health preparedness themes via BARDA R&D and ASPR medical waste disposal. The Trustees of Boston University secured the largest at $150,780,000 for antibacterial R&D (materiality 2/10, neutral signal), while INMAR RX SOLUTIONS INC received $100,289,100 for waste services (higher materiality 4/10, neutral signal). Highest-conviction signal is neutral committed revenue for both, with no profit upside for nonprofit Boston University and firm fixed price execution risks for INMAR RX SOLUTIONS INC. Dominant sector theme is sustained HHS investment in preparedness R&D and logistics. Key watch item: option exercises potentially lifting Boston University to $285.8M and INMAR RX SOLUTIONS INC to $221.1M.

2 total filings

Mega Contracts Monitor ($100M+) — April 30, 2026

These five civilian mega contracts totaling $1,106,691,471 in obligations (0/5 defense-related) highlight steady federal spending across Department of State construction, DHS UAS support, NSF IT services, and HHS health R&D/preparedness, with no defense exposure. Dominant agency themes include HHS with $251,069,100 across two awards and high-materiality bullish signals on Caddell Construction's $328.5M embassy project and Booz Allen Hamilton's $254.5M NSF IT delivery order, both fully competed with strong outlay progress on the latter. Highest-conviction signals favor established players like Caddell and Booz Allen for multi-year revenue visibility through 2025-2028. Key risk is high pricing/execution risk on firm-fixed price contracts like Caddell's $328.5M and Inmar RX's $100.3M, amplified by $0 outlays to date on Caddell.

5 total filings

High-Value Federal Grants ($5M+) — April 30, 2026

These six high-value federal grants totaling $1,188,107,721 obligation are entirely civilian (0/6 defense-related), spanning Department of State construction, DHS services, NSF IT, and HHS health R&D/waste management. Dominant themes include multi-year construction and services contracts with full obligations signaling revenue visibility, led by Caddell Construction's $328.5M State Department embassy build (bullish, materiality 8/10). Highest-conviction bullish signals emerge from Booz Allen Hamilton's $254.5M NSF IT delivery order (79% outlayed) and Rapiscan's $81.4M DHS equipment maintenance (52% outlayed), affirming public equities BAH and OSIS. Key risk is high pricing execution risk in firm-fixed-price awards like Caddell's $328.5M and Inmar RX's $100.3M, with watch on outlay progress amid low initial spends in several contracts.

NSF Science & Technology Grants — April 30, 2026

The single contract analyzed totals $254,534,977 in obligations from the National Science Foundation (NSF), representing a fully civilian award with 0/1 defense-related. Booz Allen Hamilton Inc secured this major IT services delivery order under full and open competition, signaling strong positioning in civilian government IT with $179.6M already outlayed and multi-year visibility through January 2025. The highest-conviction bullish signal is the reliable revenue stream from this non-small business win in NAICS 541511. Key watch item: progress toward full $254.5M obligation and option exercises for the additional $2.45M ceiling, given the contract's end date of January 15, 2025.

General Federal Contracts — April 30, 2026

These six civilian contracts total $1,188,107,721 in obligations with zero defense exposure, spanning Department of State, DHS (two awards), NSF, and HHS (two awards) from April 30, 2026 data. Dominant themes include large-scale construction (State embassy), IT services (NSF), health R&D and waste management (HHS), and DHS border security sustainment via UAS and inspection equipment maintenance. Highest-conviction bullish signals emerge from Caddell Construction's $328.5M firm-fixed-price embassy build in Cape Verde and Booz Allen Hamilton's $254.5M NSF IT delivery order with $179.6M outlays already recognized. Key risk is high execution/pricing risk on firm-fixed-price awards like Caddell's and Rapiscan's, coupled with low initial outlays on several contracts (e.g., Caddell's $0 outlay).

17 high priority 28 medium 45 total filings

S&P 500 Technology Sector SEC Filings — April 30, 2026

Across 45 filings dominated by Q1 2026 results and institutional 13Fs, S&P 500 Technology peers like Apple and KLA showcased robust growth with Apple posting record Q2 FY2026 revenue of $111.2B (+17% YoY) and Services +16% YoY, while KLA reported Q3 FY2026 revenue +11.5% YoY to $3.4B; however, broader filings reveal mixed sector trends with average revenue growth ~8-10% YoY in reporting companies but frequent margin compressions (e.g., -270bps at BMS, -2.4% NIM at NorthEast). Institutional 13Fs from Munich Re ($4B portfolio top NVDA/MSFT), Arista Wealth (AAPL/SPY heavy), and others confirm sustained overweight in mega-cap tech amid diversified holdings. Capital allocation trends favor shareholders with Apple's +4% dividend hike to $0.27/share and $100B buyback authorization, KLA's $1.72B repurchases, First Northern's 5% stock dividend +6% repurchase, and multiple quarterly dividends (e.g., Esquire $0.20/share). Forward guidance largely stable or upbeat (Weave FY rev $275-278M, Smurfit EBITDA $5-5.3B reaffirmed), but outliers like NCS Multistage's net loss signal caution. Portfolio-level: 7/12 growth reporters beat YoY revenue (avg +12%), but 6/10 saw margin/FFO declines; tech outliers outperform with ROE/ROA strength. Key implication: Favor tech leaders amid capital returns surge, monitor June AGMs for governance catalysts.

18 high priority 32 medium 50 total filings

Nasdaq 100 Stocks SEC Filings — April 30, 2026

Across 50 SEC filings from NASDAQ-100 constituents and related entities for the period ending April 30, 2026, Q1 2026 results reveal robust revenue growth in megacap tech (Amazon +16.6% YoY, Alphabet +21.8% YoY, Meta +33.1% YoY, Apple +17% YoY) averaging 22% YoY, offsetting margin pressures and declines in industrials/healthcare (Acadia NI -51% YoY, CPKC rev -2% YoY, Smurfit NI -83.5% YoY). Capital allocation trends emphasize shareholder returns with aggressive buybacks (CCC $400M, CPKC $680M Q1, Apple +$100B authorization) and dividends (Apple +4%, First Northern 5% stock div), alongside biotech fundraising (Intellia $194.6M extending runway to 2028, Immunic $200M). Mixed sentiment dominates (24/50 filings), driven by strong top-line but capex surges (Meta +46.7% YoY, Amazon +76.7% YoY) and exec changes (CCC CFO departure, PayPal reorg). Forward-looking catalysts cluster in June (10+ annual meetings, e.g., ImmunityBio June 9, Intellia June 9) and H2 2026 (Phase 3 data, approvals). Institutional 13G/13F filings confirm passive stakes in tech leaders (Vanguard 7.49% NFLX, 7.48% MSFT, 5.61% TSLA), signaling stability. Portfolio-level trends show 12/18 reporting companies with YoY revenue growth >10%, but 7/12 with EBITDA/operating margin contraction averaging -200bps, highlighting investment phase risks/opportunities.

US Activist Hedge Fund Institutional SEC 13D 13G — April 30, 2026

Vanguard Capital Management LLC filed seven Schedule 13G disclosures on April 30, 2026, revealing passive beneficial ownership stakes averaging 6.86% as of March 31, 2026, across Netflix (7.49%), Microsoft (7.48%), Palantir (7.28%), Warner Bros. Discovery (7.22%), PayPal and Lockheed Martin (both 6.99%), and Tesla (5.61%); the first six are newly published since the last brief, with Lockheed for context. All filings certify passive investment under Rule 13d-1(b), held via funds and managed accounts with shared voting/dispositive power and no single affiliate exceeding 5%, signaling no activist intent or control influence. Neutral sentiment prevails across all (materiality 7-8/10), highlighting Vanguard's steady index-driven positioning in tech-heavy (NFLX, MSFT, PLTR, TSLA, PYPL), media (WBD), and defense (LMT) sectors. No period-over-period ownership changes, forward-looking guidance, corporate insider trades, capital allocation shifts, M&A details, or scheduled events detailed in filings, but cross-filing pattern underscores portfolio-level stability and liquidity boost from top passive holder. Key implication: Validates mega-cap weighting in indices, with Tesla as outlier low at 5.61% potentially indicating recent threshold cross; watch for Q2 amendments amid high materiality.

7 medium 7 total filings

28 high priority 22 medium 50 total filings

S&P 500 Financials Sector SEC Filings — April 30, 2026

Across 50 filings from the USA S&P 500 Financials stream (including banks, insurers, asset managers, and related), Q1 2026 quarterly reports dominate with 70% showing revenue growth averaging +11% YoY (e.g., Hippo +10%, Southside NII +7.1%, First Northern NII +7.9%), but profitability is mixed as 55% reported net income declines or losses due to opex surges (avg +20% YoY), impairments, and margin compression (e.g., Pilgrim's EBITDA margin -520 bps to 6.8%). Financial institutions like banks (First Northern NI +61% YoY, Southside +8%) and insurers (Hippo turnaround to $7.1M NI from -$47.7M loss, Cigna adj inc +12%) outperform non-financial outliers, signaling sector resilience amid deposit softness and NIM stability. Capital allocation remains shareholder-friendly with buybacks (e.g., Southside authorized 6%, Moelis $117M) and dividends (e.g., First Northern 5% stock dividend), though cash flows weaken QoQ in 60% of cases (avg -15%). Forward-looking guidance is raised in key names (Hippo GWP to $1.45-1.525B, Cigna FY adj EPS $30.35+), building a positive catalyst calendar into H2 2026. Portfolio-level trends highlight relative outperformance in regional banks (ROAA avg 1.2% up YoY) vs broader pressures from impairments and capex, implying tactical overweight in profitable financials with strong liquidity (net leverage <2x). Overall sentiment mixed (65% of filings), with actionable alpha in insurer turnarounds and bank deposit betas.

20 high priority 30 medium 50 total filings

S&P 500 Consumer Staples Sector SEC Filings — April 30, 2026

Across 50 SEC filings from the USA S&P 500 Consumer Staples stream (broadly including adjacent sectors like food/beverages, household products, and related), Q1 2026 results reveal robust revenue growth averaging +25% YoY in 12/18 reporting companies (e.g., Angel Studios +143%, Eli Lilly +56%, Glaukos +41%), driven by pricing power and volume in select areas, though staples volumes declined (Molson Coors -2.9%, Altria cigarettes -2.4% adjusted, Hershey -2 points). Margin trends mixed with expansions in 7/15 (e.g., Angel +300bps to 62%, Iron Mountain +20bps to 36.6%) offset by compressions (Hershey salty snacks -530bps, UMC -590bps gross). Capital returns strong via buybacks ($2.4B aggregate noted, e.g., CCC $400M, Altria $280M) and dividends (Altria $1.8B, Hershey reaffirmed), but cash piles declined QoQ in 10/15 (avg -20%). Guidance raised in 6 key names (Eli Lilly rev to $82-85B, Iron Mountain EBITDA +14%, Garrett sales to $3.6-3.9B), signaling conviction amid mixed sentiment (14/20 mixed). Portfolio-level theme: Pricing offsets volume weakness in staples; watch biotech/health adjacents for outsized growth. Critical implication: Favor raised-guidance leaders for near-term upside, hedge volume risks in beverages/tobacco.